Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Early NK Cell Reconstitution Predicts Overall Survival in T-Cell Replete Allogeneic Hematopoietic Stem Cell Transplantation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


Vis graf over relationer

Early immune reconstitution plays a critical role in clinical outcome after allogeneic hematopoietic stem cell transplantation (HSCT). Natural killer (NK) cells are the first lymphocytes to recover after transplantation and are considered powerful effector cells in HSCT. We aimed to evaluate the clinical impact of early NK cell recovery in T-cell replete transplant recipients. Immune reconstitution was studied in 298 adult patients undergoing HSCT for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS) from 2005 to 2013. In multivariate analysis NK cell numbers day 30 (NK30) >150cells/µL were independently associated with superior overall survival (hazard ratio 0.79, 95% confidence interval 0.66-0.95, p=0.01). Cumulative incidence analyses showed that patients with NK30 >150cells/µL had significantly less transplant related mortality (TRM), p=0.01. Patients with NK30 >150cells/µL experienced significantly lower numbers of life threatening bacterial infections as well as viral infections, including CMV. No association was observed in relation to relapse. These results suggest an independent protective effect of high early NK cell reconstitution on TRM which translates into improved overall survival after T-cell replete HSCT.

TidsskriftBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Udgave nummer12
Sider (fra-til)2187-2193
Antal sider7
StatusUdgivet - 21 sep. 2016

ID: 48989523